PepGen
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. Its lead product candidates comprise PGN-EDO51, an EDO peptide which is Phase 2 clinical trial to ...
PepGen Logo
About PepGen
PepGen Inc. operates as a clinical-stage biotechnology company. The Company focuses on developing next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. PepGen serves customers worldwide.
Address
321 Harrison Avenue, 8th Floor
Boston, 02118
United States
Year founded
2020
Number of employees
0-100
Report inaccurate data
Request an update to help us keep the brand up-to-date.
